InSite Vision Announces Appeal by Sandoz Inc. of Court Judgment Upholding All AzaSite Patents in Patent Infringement Lawsuit

06-11-2013 Business Wire HealthComments (0)

AzaSitePharmaceuticalSandoz

InSite Vision Incorporated (OTCBB: INSV) today announced that Sandoz Inc. has filed an appeal of the court judgment that recently upheld the patents protecting AzaSite® (azithromycin 1% ophthalmic solution). The appeal was filed in the United States Court of Appeals for the Federal Circuit. On October 7, 2013, InSite Vision announced that the United States District Court for the District of New Jersey had upheld all four of the patents protecting AzaSite in a p

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top